back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-06-07 15:22 Tx date 2024-06-03 |
$AEZS
Aeterna Zentaris Inc. |
Gagnon, Gilles
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+17,936 vol |
17,936 | |
| Filed 2024-06-07 15:22 Tx date 2020-01-01 |
$AEZS
Aeterna Zentaris Inc. |
Gagnon, Gilles
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-06-07 15:22 Tx date 2024-06-03 |
$AEZS
Aeterna Zentaris Inc. |
Gagnon, Gilles
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Prodev Pharma Inc. (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+5,900 vol |
5,900 | |
| Filed 2024-06-07 15:21 Tx date 2020-01-01 |
$AEZS
Aeterna Zentaris Inc. |
Gagnon, Gilles
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Prodev Pharma Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-06-07 15:20 Tx date 2024-06-03 |
$AEZS
Aeterna Zentaris Inc. |
Gagnon, Gilles
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+36,062 vol |
36,062 | |
| Filed 2024-06-07 15:20 Tx date 2020-01-01 |
$AEZS
Aeterna Zentaris Inc. |
Gagnon, Gilles
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-06-07 15:16 Tx date 2024-06-03 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-700,000 vol |
0 | |
| Filed 2024-06-07 15:15 Tx date 2024-06-03 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Holder: Prodev Pharma Inc. (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-250,000 vol |
0 | |
| Filed 2024-06-07 15:15 Tx date 2024-06-03 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-1,489,000 vol |
0 | |
| Filed 2024-06-05 18:31 Tx date 2024-05-03 |
$AEZS
Aeterna Zentaris Inc. |
Gagnon, Gilles
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
37 - Stock split or consolidation
|
-36,750 vol |
12,250 | |
| Filed 2024-01-10 15:57 Tx date 2024-01-04 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-23,100
-60,000 vol $0.385 each |
700,000 | |
| Filed 2023-06-14 16:13 Tx date 2023-06-14 |
$AEZS
AEterna Zentaris Inc. |
Gagnon, Gilles
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+25,000 vol |
49,000 | |
| Filed 2023-01-05 16:58 Tx date 2023-01-03 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$93,000
+150,000 vol $0.62 each |
760,000 | |
| Filed 2022-08-08 17:18 Tx date 2022-08-03 |
$AEZS
AEterna Zentaris Inc. |
Gagnon, Gilles
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+20,000 vol |
24,000 | |
| Filed 2022-08-08 17:18 Tx date 2022-07-21 |
$AEZS
AEterna Zentaris Inc. |
Gagnon, Gilles
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
37 - Stock split or consolidation
|
-96,000 vol |
4,000 | |
| Filed 2022-07-19 14:46 Tx date 2022-07-15 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-15,000
-150,000 vol $0.10 each |
610,000 | |
| Filed 2022-07-19 14:38 Tx date 2022-07-15 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$15,000
+150,000 vol $0.10 each |
1,489,000 | |
| Filed 2021-05-20 22:48 Tx date 2021-05-19 |
$AEZS
AEterna Zentaris Inc. |
Gagnon, Gilles
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+70,000 vol |
100,000 | |
| Filed 2020-05-21 15:30 Tx date 2020-05-15 |
$AEZS
AEterna Zentaris Inc. |
Gagnon, Gilles
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+30,000 vol |
30,000 | |
| Filed 2020-05-21 15:29 Tx date 2020-01-01 |
$AEZS
AEterna Zentaris Inc. |
Gagnon, Gilles
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-02-11 11:24 Tx date 2020-02-07 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Holder: Prodev Pharma Inc. (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
$15,200
+40,000 vol $0.38 each |
250,000 | |
| Filed 2020-02-11 11:23 Tx date 2020-02-07 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Holder: Prodev Pharma Inc. (Indirect Ownership)
|
Restricted Share Unit
57 - Exercise of rights
|
-40,000 vol |
0 | |
| Filed 2020-01-16 11:08 Tx date 2020-01-15 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$22,140
+54,000 vol $0.41 each |
1,339,000 | |
| Filed 2020-01-14 12:34 Tx date 2020-01-10 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Holder: Prodev Pharma Inc. (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
$9,600
+30,000 vol $0.32 each |
210,000 | |
| Filed 2020-01-14 12:33 Tx date 2020-01-10 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Holder: Prodev Pharma Inc. (Indirect Ownership)
|
Restricted Share Unit
57 - Exercise of rights
|
-30,000 vol |
40,000 | |
| Filed 2020-01-06 16:46 Tx date 2020-01-03 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Holder: Prodev Pharma Inc. (Indirect Ownership)
|
Restricted Share Unit
56 - Grant of rights
|
+40,000 vol |
70,000 | |
| Filed 2020-01-06 16:45 Tx date 2020-01-03 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$21,600
+60,000 vol $0.36 each |
760,000 | |
| Filed 2019-07-10 11:22 Tx date 2019-07-08 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Holder: Prodev Pharma Inc. (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
$10,200
+30,000 vol $0.34 each |
180,000 | |
| Filed 2019-07-10 11:20 Tx date 2019-07-08 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Holder: Prodev Pharma Inc. (Indirect Ownership)
|
Restricted Share Unit
57 - Exercise of rights
|
-30,000 vol |
30,000 | |
| Filed 2019-06-27 13:11 Tx date 2019-06-26 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-12,500
-125,000 vol $0.10 each |
700,000 | |
| Filed 2019-06-27 13:04 Tx date 2019-06-26 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$12,500
+125,000 vol $0.10 each |
1,285,000 | |
| Filed 2019-01-07 Tx date 2019-01-04 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$23,100
+60,000 vol $0.385 each |
825,000 | |
| Filed 2019-01-07 Tx date 2019-01-04 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Holder: Prodev Pharma Inc. (Indirect Ownership)
|
Restricted Share Unit
56 - Grant of rights
|
+30,000 vol |
30,000 | |
| Filed 2019-01-07 Tx date 2019-01-04 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Holder: Prodev Pharma Inc. (Indirect Ownership)
|
Restricted Share Unit
56 - Grant of rights
|
+30,000 vol |
60,000 | |
| Filed 2018-01-23 Tx date 2018-01-19 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Holder: Prodev Pharma Inc. (Indirect Ownership)
|
Restricted Share Unit
57 - Exercise of rights
|
-150,000 vol |
0 | |
| Filed 2018-01-23 Tx date 2007-09-25 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Holder: Prodev Pharma Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-01-23 Tx date 2018-01-19 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Holder: Prodev Pharma Inc. (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
$75,000
+150,000 vol $0.50 each |
150,000 | |
| Filed 2018-01-05 Tx date 2007-09-25 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Holder: Prodev Pharma Inc. (Indirect Ownership)
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-01-05 Tx date 2018-01-02 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Holder: Prodev Pharma Inc. (Indirect Ownership)
|
Restricted Share Unit
56 - Grant of rights
|
+150,000 vol |
150,000 | |
| Filed 2017-11-02 Tx date 2017-10-30 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-16,000
-160,000 vol $0.10 each |
765,000 | |
| Filed 2017-11-02 Tx date 2017-10-30 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$16,000
+160,000 vol $0.10 each |
1,160,000 | |
| Filed 2017-01-05 Tx date 2017-01-03 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$700,000
+400,000 vol $1.75 each |
925,000 | |
| Filed 2015-10-20 Tx date 2015-10-15 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$14,000
+140,000 vol $0.10 each |
1,000,000 | |
| Filed 2015-10-20 Tx date 2015-10-15 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$7,500
+50,000 vol $0.15 each |
860,000 | |
| Filed 2015-10-20 Tx date 2015-10-15 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-7,500
-50,000 vol $0.15 each |
665,000 | |
| Filed 2015-10-20 Tx date 2015-10-15 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-14,000
-140,000 vol $0.10 each |
525,000 | |
| Filed 2015-08-10 Tx date 2015-08-05 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-6,000
-60,000 vol $0.10 each |
715,000 | |
| Filed 2015-08-10 Tx date 2015-08-05 |
$CZO
Ceapro Inc. |
Gagnon, Gilles
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$6,000
+60,000 vol $0.10 each |
810,000 |